10 February 2004 – Davos – Young adults, aged between 18 and 30, diagnosed with schizophrenia and considered symptomatically stable on their antipsychotic treatment, experience significant ...
SAN FRANCISCO, May 19, 2009 – New data demonstrate that maintenance therapy with RISPERDAL® CONSTA® (risperidone) Long-Acting Treatment (RLAT) significantly delayed the time to relapse compared to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results